A nomenclature system for metabolic gene polymorphisms.

Area of Science:

• Pharmacogenomics
• Human Genetics
• Molecular Biology

Background:

• Diverse and inconsistent nomenclature systems exist for human metabolic gene polymorphisms.
• This ambiguity complicates data interpretation and cross-study comparisons in pharmacogenomics and drug metabolism research.
• Key gene families affected include cytochrome P450 (CYP), glutathione S-transferase (GST), and N-acetyltransferase (NAT).

Purpose of the Study:

• To propose a unified and standardized nomenclature system for human metabolic gene polymorphisms.
• To replace the fragmented and often conflicting naming conventions currently in use.
• To enhance clarity and consistency in the reporting of genetic variations.

Main Methods:

• The proposed system builds upon existing nomenclature proposals for CYP2D6 and NAT alleles.
• It employs a structured format: gene name, asterisk, chronological arabic number for the polymorphism, and optional letters for allelic subtypes.
• A comprehensive table details nomenclature for 72 polymorphisms across 12 genes, including previous designations.

Main Results:

• A systematic nomenclature is presented for 72 polymorphisms within 12 human metabolic genes.
• The system provides clear designations, resolving ambiguities from previous naming conventions.
• Detailed descriptions and cross-references to prior nomenclature are included.

Conclusions:

• The proposed nomenclature offers a standardized framework for human metabolic gene polymorphisms.
• Adoption of this system will improve consistency in scientific literature and databases.
• This standardization is crucial for advancing research in drug metabolism, personalized medicine, and genetic epidemiology.